EVs have only recently been studied in the context of Chronic Myeloid Leukemia (CML), a blood malignancy defined by the chromosomal rearrangement t(9;22) and the fusion gene BCR-ABL1. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.